InsiderTrades

Form 4 for HUM Humana

Accepted 2022-11-07 00:00:00 ET · period of report 2022-11-03 · accession 0001062993-22-021633 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2022-11-07 2022-11-03 HUM Fleming William Kevin Seg Pres, Pharmacy Sol, CCAO M - OptEx $324.46 +11.2K 13.7K +439% +$3.62M
D 2022-11-07 2022-11-03 HUM Fleming William Kevin Seg Pres, Pharmacy Sol, CCAO G - Gift $0.00 -900 1,642 -35% $0
D 2022-11-07 2022-11-03 HUM Fleming William Kevin Seg Pres, Pharmacy Sol, CCAO S - Sale+OE $565.61 -11.2K 2,542 -81% -$6.31M
DM 2022-11-07 2022-11-03 HUM Fleming William Kevin Seg Pres, Pharmacy Sol, CCAO M - OptEx $0.00 -11.2K 324 -97% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Humana Common 2022-11-03 M A 6,860 $307.97 9,402 D — —
2 Common Humana Common 2022-11-03 G D 900 $0.00 1,642 D — — (F13) Shares disposed of represent gift/charitable donation, effective November 3, 2022, in which no value was received in return.
3 Common Humana Common 2022-11-03 S D 11,157 $565.61 2,542 D — — (F14) Price reported is weighted average sales price.
4 Common Humana Common 2022-11-03 M A 4,297 $350.79 13,699 D — —
5 Derivative Options 2022-11-03 M D 4,297 $0.00 2,149 D $350.79 · — to 2027-02-24 4,297 Humana Common (F4) Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/2020, vesting in three annual increments from 2/24/21 to 2/24/23.
6 Derivative Options 2022-11-03 M D 6,860 $0.00 324 D $307.97 · — to 2026-02-25 6,860 Humana Common (F3) Right to buy pursuant to Company's 2011 Stock Incentive Plan. Non-Qualified stock options granted to reporting person on 02/25/2019, vesting in three increments from 2/25/20 to 2/25/22.